XML 113 R44.htm IDEA: XBRL DOCUMENT
v3.23.1

Earnings per share (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2022
Earnings per share [abstract] |
Earnings per share |
|  | 2022 |  | 2021 |  | 2020 |
Net income attributable to shareholders of Novartis AG (USD millions) |  | 6 955 |  | 24 021 |  | 8 072 |
Number of shares (in millions) |  |  |  |  |  |  |
Weighted average number of shares outstanding used in basic earnings per share |  | 2 181 |  | 2 243 |  | 2 277 |
Adjustment for vesting of restricted shares, restricted share units and dilutive shares from options |  | 16 |  | 17 |  | 19 |
Weighted average number of shares in diluted earnings per share |  | 2 197 |  | 2 260 |  | 2 296 |
Basic earnings per share (USD) |  | 3.19 |  | 10.71 |  | 3.55 |
Diluted earnings per share (USD) |  | 3.17 |  | 10.63 |  | 3.52 |

X
- References No definition available. + Details
Name: | ifrs-full_EarningsPerShareAbstract
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | nvs_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | nvs_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration